Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals struggling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://sachinshmy339012.blogsuperapp.com/41079804/tirzepatide-a-game-changer-for-type-2-diabetes